RALLYBIO CORPORATION (RLYB)

Every figure this model derived for RLYB, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2024-12-31
cash 92,849,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 97,253,000 AssetsCurrent 2026-06-30
current liabilities 3,567,000 LiabilitiesCurrent 2026-06-30
equity 94,496,000 StockholdersEquity 2026-06-30
ocf 26,712,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 646,000 Revenues 2026-06-30
sbc 2,858,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up RLYB on one particular measure came for.

RatioValue
current ratio27.26
current ratio reported27.26
deferred revenue growth-100.0
dilution pct3.42
revenue growth-15.11
revenue growth per share-17.92
roic-1329.76
rule of 40-4306.6
sbc pct revenue442.41

What to be careful about

What this model itself distrusts about RLYB's figures. Written by the derivation as it ran, not added afterwards.